See up to 3 months of NVNO. The 7-day demo opens the 1M and 3M ranges and puts NVNO on your watchlist.
Start 7-day demoLatest NVNO insider trades
Francis Duhay - DirectorOpen-market sale$123- Francis Duhay - DirectorOpen-market sale$1K
About enVVeno Medical Corp (NVNO)
enVVeno Medical Corp is an SEC registrant, filing under CIK 0001661053, classified as surgical and medical instruments and apparatus. It is grouped with Health Care companies on this site.
NVNO Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 11 | $123 |
NVNO insider transactions (Form 4)
1818 Form 4 filings on record, the earliest from Dec 20, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Francis Duhay - Director | Open-market sale | Common Stock | 11 | $11.21 | $123 | |
| Francis Duhay - Director | Open-market sale | Common Stock | 140 | $10.31 | $1K | |
| Francis Duhay - Director | Open-market sale | Common Stock | 140 | $11.52 footnote F2 | $2K | |
| ||||||
| Robert Andrew Berman - Officer | Other | Restricted Stock Units | 200,000 | $0.00 | - | |
| Hamed Alavi - Officer | Other | Restricted Stock Units | 50,000 | $0.00 | - | |
| Marc H. Glickman - Officer | Other | Restricted Stock Units | 100,000 | $0.00 | - | |
| Francis Duhay - Director | Open-market sale | Common Stock | 4,900 | $0.36 footnote F2 | $2K | |
| ||||||
| Francis Duhay - Director | Open-market sale | Common Stock | 4,900 | $0.83 | $4K | |
| Sanjay Shrivastava - Director | Open-market purchase | Common Stock | 5,400 | $2.90 | $16K | |
| Matthew Jenusaitis - Director | Open-market purchase | Common Stock | 9,620 | $2.53 | $24K | |
| Robert Andrew Berman - Officer | Open-market purchase | Common Stock | 12,000 | $2.55 | $31K | |
| Sanjay Shrivastava - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Robert Gray - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Marc H. Glickman - Officer | Grant or award | Stock Options | 75,000 | $0.00 | - | |
| Hamed Alavi - Officer | Grant or award | Stock Options | 75,000 | $0.00 | - | |
| Francis Duhay - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Matthew Jenusaitis - Director | Grant or award | Stock Options | 19,752 | $0.00 | - | |
| Robert Andrew Berman - Officer | Grant or award | Stock Options | 200,000 | $0.00 | - | |
Recent NVNO Form 144 notices of proposed sale
2An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Duhay Francis | Director | 11 | $123 | View on EDGAR | |
| - | - | - | - |
NVNO insider trading FAQ
What is the latest insider trade for NVNO?
enVVeno Medical Corp (NVNO) had 1 insider filing in the last 90 days, with the most recent on 2026-09-14. The full record for NVNO runs to 18 Form 4 filings, the earliest from 2024-12-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying NVNO stock?
No insider purchases of NVNO were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling NVNO stock?
1 insider sale of NVNO was filed in the last 90 days, totaling $123.
Where can I see NVNO SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects NVNO Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Francis Duhay view on EDGAR
- - Francis Duhay view on EDGAR
- - Francis Duhay view on EDGAR
- - Robert Andrew Berman view on EDGAR
- - Hamed Alavi view on EDGAR
- - Marc H. Glickman view on EDGAR
- - Francis Duhay view on EDGAR
- - Francis Duhay view on EDGAR
- - Sanjay Shrivastava view on EDGAR
- - Matthew Jenusaitis
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where NVNO's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow NVNO with a 7-day demo
- NVNO on your watchlist
- Every NVNO Form 4 filing on record
- Up to 3 months of NVNO price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
